Therefore, in the present study, the lack of significant overexpression of the cyclin D1 or B1 proteins in the icodextrin-treated ovarian cancer cell lines, in either a dose- or time-dependent manner, further strongly suggests that icodextrin does not promote ovarian cancer cell proliferation. Here, CCND1 is linked to ovarian carcinoma.